PhRMA Public Affairs Calendar For February
Tuesday February 1: CEO edit call (Zenner); State Media tours on price controls begin
You may also be interested in...
PhRMA's new chief lobbyist heading into the 2000 Medicare reform debate will be former TRW VP-Government Relations James Christy.
The failure of the SGLT2 inhibitor is not unexpected, but allays any concerns that it could have worsened outcomes for patients with hypertension or heart disease.